BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #911BiotechnologyInfectious Disease
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±3.8%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+4.1%
Worst reaction-17.9%

Stock move on the day after each report

-4.4%2023/Q4+0.7%2024/Q1-4.5%2024/Q2-2.3%2024/Q3-3.2%2024/Q4-3.7%2025/Q1+2.5%2025/Q2+0.0%2025/Q3-17.9%2025/Q4-3.9%2026/Q1-1.0%2026/Q2-0.7%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q33 Nov 2026None±8.4%-0.70%Within range
2026/Q24 Aug 2026Pre Market±7.3%-0.98%Within range
2026/Q15 May 2026Pre Market±7.4%-3.88%Within range
2025/Q410 Mar 2026Pre Market±6.7%-17.88%Bigger than priced
2025/Q33 Nov 2025Pre Market±7.1%+0.04%Within range
2025/Q24 Aug 2025None±8.6%+2.51%Within range
2025/Q15 May 2025Pre Market±10.7%-3.66%Within range
2024/Q410 Mar 2025None±10.8%-3.15%Within range
2024/Q34 Nov 2024Pre Market±9.5%-2.25%Within range
2024/Q25 Aug 2024None±6.2%-4.45%Within range
2024/Q16 May 2024None±6.4%+0.68%Within range
2023/Q420 Mar 2024None±10.1%-4.38%Within range
2023/Q36 Nov 2023Pre Market±8.6%+4.10%Within range
2023/Q27 Aug 2023None±8.4%-7.49%Within range
2023/Q18 May 2023None±7.2%-0.35%Within range
2022/Q427 Mar 2023Pre Market±6.0%-3.59%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€1.29B-15.1% YoY
Operating profit€138.10M-78.9% YoY
Net profit€184.50M+742.9% YoY
Diluted EPS€0.73+708.3% YoY
Free cash flow-€178.30M-124.0% YoY
Operating cash flow-€129.80M

Revenue, last 8 quarters

€1.2BDec '24€182.8MMar '25€260.8MJun '25€1.5BSep '25€907.4MDec '25€118.1MMar '26€105.6MJun '26€1.3BSep '26

Net profit, last 8 quarters

€259.5MDec '24€-415.8MMar '25€-386.6MJun '25€-28.7MSep '25€-305.0MDec '25€-531.9MMar '26€-820.8MJun '26€184.5MSep '26

Profitability & balance sheet

Gross margin75.0%
Operating margin-72.7%
Net margin-60.9%
Return on equity-8.1%
Return on assets-7.1%
Return on invested capital-8.0%
Current ratio8.55
Liabilities / assets12.2%
Cash & investments€14.66B
Total debt€312.80M
Net cash (debt)€14.34B

Discussion

No comments yet — be the first to weigh in on BNTX.

Sign in to join the discussion.

Scroll to Top